CD26 as a target against fibrous formation in chronic airway rejection lesions-Reference-Cited by-同舟云学术

CD26 as a target against fibrous formation in chronic airway rejection lesions

Published:2021-08 Issue: Volume:278 Page:119496
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Jungraithmayr Wolfgang,Yamada Yoshito,Haberecker Martina,Breuer Eva,Schuurmans Macé,Dubs Linus,Itani Saria,Janker Florian,Weder Walter,Opitz Isabelle,Jang Jae-Hwi

Funder

Kurt und Senta Herrmann Stiftung

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference37 articles.

1. The collaborative transplant study registry;Opelz;Transplant Rev (Orlando),2013

2. Chronic lung allograft dysfunction after lung transplantation: the moving target;Sato;Gen. Thorac. Cardiovasc. Surg.,2013

3. When tissue is the issue: a histological review of chronic lung allograft dysfunction;Verleden;Am. J. Transplant.,2020

4. A new classification system for chronic lung allograft dysfunction;Verleden;J. Heart Lung Transplant.,2014

5. Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis;Ofek;Mod. Pathol.,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Favorable effect of CD26/DPP-4 inhibitors on postoperative outcomes after lung transplantation: A propensity-weighted analysis;The Journal of Heart and Lung Transplantation;2024-01

2. Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis;British Journal of Pharmacology;2022-11

3. Perioperative diabetes mellitus affects the outcomes of lung transplant recipients;European Journal of Cardio-Thoracic Surgery;2022-06-09